0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leukapheresis Device Market Research Report 2026
Published Date: 2026-03-27
|
Report Code: QYRE-Auto-18F17292
Home | Market Reports
Global Leukapheresis Device Market Research Report 2024
BUY CHAPTERS

Global Leukapheresis Device Market Research Report 2026

Code: QYRE-Auto-18F17292
Report
2026-03-27
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Leukapheresis Device Market

The global Leukapheresis Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Leukapheresis Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Leukapheresis Device is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Leukapheresis Device is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Leukapheresis Device include Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Leukapheresis Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Leukapheresis Device. The Leukapheresis Device market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Leukapheresis Device market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Leukapheresis Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Leukapheresis Device Market Report

Report Metric Details
Report Name Leukapheresis Device Market
Segment by Type
  • Monoclonal Acquisition Equipment
  • Leukocyte Separation Column
  • Leukocyte Removal Filter
  • Other
by Application
  • Academic Research
  • Clinical Treatment
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, Lonza, Grifols, Kaneka Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Leukapheresis Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Leukapheresis Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Leukapheresis Device Market report?

Ans: The main players in the Leukapheresis Device Market are Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, Lonza, Grifols, Kaneka Medical

What are the Application segmentation covered in the Leukapheresis Device Market report?

Ans: The Applications covered in the Leukapheresis Device Market report are Academic Research, Clinical Treatment, Other

What are the Type segmentation covered in the Leukapheresis Device Market report?

Ans: The Types covered in the Leukapheresis Device Market report are Monoclonal Acquisition Equipment, Leukocyte Separation Column, Leukocyte Removal Filter, Other

1 Leukapheresis Device Market Overview
1.1 Product Definition
1.2 Leukapheresis Device by Type
1.2.1 Global Leukapheresis Device Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Acquisition Equipment
1.2.3 Leukocyte Separation Column
1.2.4 Leukocyte Removal Filter
1.2.5 Other
1.3 Leukapheresis Device by Application
1.3.1 Global Leukapheresis Device Market Value by Application: 2025 vs 2032
1.3.2 Academic Research
1.3.3 Clinical Treatment
1.3.4 Other
1.4 Global Leukapheresis Device Market Size Estimates and Forecasts
1.4.1 Global Leukapheresis Device Revenue 2021–2032
1.4.2 Global Leukapheresis Device Sales 2021–2032
1.4.3 Global Leukapheresis Device Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Leukapheresis Device Market Competition by Manufacturers
2.1 Global Leukapheresis Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Leukapheresis Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Leukapheresis Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Leukapheresis Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Leukapheresis Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Leukapheresis Device, Product Types and Applications
2.7 Global Key Manufacturers of Leukapheresis Device, Date of Entry into the Industry
2.8 Global Leukapheresis Device Market Competitive Situation and Trends
2.8.1 Global Leukapheresis Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Leukapheresis Device Players Market Share by Revenue
2.8.3 Global Leukapheresis Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Leukapheresis Device Market Scenario by Region
3.1 Global Leukapheresis Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Leukapheresis Device Sales by Region: 2021–2032
3.2.1 Global Leukapheresis Device Sales by Region: 2021–2026
3.2.2 Global Leukapheresis Device Sales by Region: 2027–2032
3.3 Global Leukapheresis Device Revenue by Region: 2021–2032
3.3.1 Global Leukapheresis Device Revenue by Region: 2021–2026
3.3.2 Global Leukapheresis Device Revenue by Region: 2027–2032
3.4 North America Leukapheresis Device Market Facts & Figures by Country
3.4.1 North America Leukapheresis Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Leukapheresis Device Sales by Country (2021–2032)
3.4.3 North America Leukapheresis Device Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Leukapheresis Device Market Facts & Figures by Country
3.5.1 Europe Leukapheresis Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Leukapheresis Device Sales by Country (2021–2032)
3.5.3 Europe Leukapheresis Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leukapheresis Device Market Facts & Figures by Region
3.6.1 Asia Pacific Leukapheresis Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Leukapheresis Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Leukapheresis Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Leukapheresis Device Market Facts & Figures by Country
3.7.1 Latin America Leukapheresis Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Leukapheresis Device Sales by Country (2021–2032)
3.7.3 Latin America Leukapheresis Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Leukapheresis Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Leukapheresis Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Leukapheresis Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Leukapheresis Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Leukapheresis Device Sales by Type (2021–2032)
4.1.1 Global Leukapheresis Device Sales by Type (2021–2026)
4.1.2 Global Leukapheresis Device Sales by Type (2027–2032)
4.1.3 Global Leukapheresis Device Sales Market Share by Type (2021–2032)
4.2 Global Leukapheresis Device Revenue by Type (2021–2032)
4.2.1 Global Leukapheresis Device Revenue by Type (2021–2026)
4.2.2 Global Leukapheresis Device Revenue by Type (2027–2032)
4.2.3 Global Leukapheresis Device Revenue Market Share by Type (2021–2032)
4.3 Global Leukapheresis Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Leukapheresis Device Sales by Application (2021–2032)
5.1.1 Global Leukapheresis Device Sales by Application (2021–2026)
5.1.2 Global Leukapheresis Device Sales by Application (2027–2032)
5.1.3 Global Leukapheresis Device Sales Market Share by Application (2021–2032)
5.2 Global Leukapheresis Device Revenue by Application (2021–2032)
5.2.1 Global Leukapheresis Device Revenue by Application (2021–2026)
5.2.2 Global Leukapheresis Device Revenue by Application (2027–2032)
5.2.3 Global Leukapheresis Device Revenue Market Share by Application (2021–2032)
5.3 Global Leukapheresis Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Asahi Kasei Medical
6.1.1 Asahi Kasei Medical Company Information
6.1.2 Asahi Kasei Medical Description and Business Overview
6.1.3 Asahi Kasei Medical Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Asahi Kasei Medical Leukapheresis Device Product Portfolio
6.1.5 Asahi Kasei Medical Recent Developments/Updates
6.2 Haemonetics
6.2.1 Haemonetics Company Information
6.2.2 Haemonetics Description and Business Overview
6.2.3 Haemonetics Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Haemonetics Leukapheresis Device Product Portfolio
6.2.5 Haemonetics Recent Developments/Updates
6.3 TERUMO BCT
6.3.1 TERUMO BCT Company Information
6.3.2 TERUMO BCT Description and Business Overview
6.3.3 TERUMO BCT Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TERUMO BCT Leukapheresis Device Product Portfolio
6.3.5 TERUMO BCT Recent Developments/Updates
6.4 STEMCELL Technologies
6.4.1 STEMCELL Technologies Company Information
6.4.2 STEMCELL Technologies Description and Business Overview
6.4.3 STEMCELL Technologies Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 STEMCELL Technologies Leukapheresis Device Product Portfolio
6.4.5 STEMCELL Technologies Recent Developments/Updates
6.5 Fresenius
6.5.1 Fresenius Company Information
6.5.2 Fresenius Description and Business Overview
6.5.3 Fresenius Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fresenius Leukapheresis Device Product Portfolio
6.5.5 Fresenius Recent Developments/Updates
6.6 B. Braun Melsungen
6.6.1 B. Braun Melsungen Company Information
6.6.2 B. Braun Melsungen Description and Business Overview
6.6.3 B. Braun Melsungen Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B. Braun Melsungen Leukapheresis Device Product Portfolio
6.6.5 B. Braun Melsungen Recent Developments/Updates
6.7 AllCells
6.7.1 AllCells Company Information
6.7.2 AllCells Description and Business Overview
6.7.3 AllCells Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AllCells Leukapheresis Device Product Portfolio
6.7.5 AllCells Recent Developments/Updates
6.8 StemExpress
6.8.1 StemExpress Company Information
6.8.2 StemExpress Description and Business Overview
6.8.3 StemExpress Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 StemExpress Leukapheresis Device Product Portfolio
6.8.5 StemExpress Recent Developments/Updates
6.9 Charles River
6.9.1 Charles River Company Information
6.9.2 Charles River Description and Business Overview
6.9.3 Charles River Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Charles River Leukapheresis Device Product Portfolio
6.9.5 Charles River Recent Developments/Updates
6.10 Precision for Medicine
6.10.1 Precision for Medicine Company Information
6.10.2 Precision for Medicine Description and Business Overview
6.10.3 Precision for Medicine Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Precision for Medicine Leukapheresis Device Product Portfolio
6.10.5 Precision for Medicine Recent Developments/Updates
6.11 Lonza
6.11.1 Lonza Company Information
6.11.2 Lonza Description and Business Overview
6.11.3 Lonza Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Lonza Leukapheresis Device Product Portfolio
6.11.5 Lonza Recent Developments/Updates
6.12 Grifols
6.12.1 Grifols Company Information
6.12.2 Grifols Description and Business Overview
6.12.3 Grifols Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Grifols Leukapheresis Device Product Portfolio
6.12.5 Grifols Recent Developments/Updates
6.13 Kaneka Medical
6.13.1 Kaneka Medical Company Information
6.13.2 Kaneka Medical Description and Business Overview
6.13.3 Kaneka Medical Leukapheresis Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Kaneka Medical Leukapheresis Device Product Portfolio
6.13.5 Kaneka Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leukapheresis Device Industry Chain Analysis
7.2 Leukapheresis Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leukapheresis Device Production Mode & Process Analysis
7.4 Leukapheresis Device Sales and Marketing
7.4.1 Leukapheresis Device Sales Channels
7.4.2 Leukapheresis Device Distributors
7.5 Leukapheresis Device Customer Analysis
8 Leukapheresis Device Market Dynamics
8.1 Leukapheresis Device Industry Trends
8.2 Leukapheresis Device Market Drivers
8.3 Leukapheresis Device Market Challenges
8.4 Leukapheresis Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Leukapheresis Device Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Leukapheresis Device Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Leukapheresis Device Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Leukapheresis Device Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Leukapheresis Device Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Leukapheresis Device Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Leukapheresis Device Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Leukapheresis Device Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Leukapheresis Device, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Leukapheresis Device, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Leukapheresis Device, Product Types and Applications
 Table 12. Global Key Manufacturers of Leukapheresis Device, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Leukapheresis Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Leukapheresis Device Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Leukapheresis Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Leukapheresis Device Sales by Region (K Units), 2021–2026
 Table 18. Global Leukapheresis Device Sales Market Share by Region (2021–2026)
 Table 19. Global Leukapheresis Device Sales by Region (K Units), 2027–2032
 Table 20. Global Leukapheresis Device Sales Market Share by Region (2027–2032)
 Table 21. Global Leukapheresis Device Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Leukapheresis Device Revenue Market Share by Region (2021–2026)
 Table 23. Global Leukapheresis Device Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Leukapheresis Device Revenue Market Share by Region (2027–2032)
 Table 25. North America Leukapheresis Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Leukapheresis Device Sales by Country (K Units), 2021–2026
 Table 27. North America Leukapheresis Device Sales by Country (K Units), 2027–2032
 Table 28. North America Leukapheresis Device Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Leukapheresis Device Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Leukapheresis Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Leukapheresis Device Sales by Country (K Units), 2021–2026
 Table 32. Europe Leukapheresis Device Sales by Country (K Units), 2027–2032
 Table 33. Europe Leukapheresis Device Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Leukapheresis Device Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Leukapheresis Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Leukapheresis Device Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Leukapheresis Device Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Leukapheresis Device Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Leukapheresis Device Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Leukapheresis Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Leukapheresis Device Sales by Country (K Units), 2021–2026
 Table 42. Latin America Leukapheresis Device Sales by Country (K Units), 2027–2032
 Table 43. Latin America Leukapheresis Device Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Leukapheresis Device Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Leukapheresis Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Leukapheresis Device Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Leukapheresis Device Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Leukapheresis Device Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Leukapheresis Device Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Leukapheresis Device Sales (K Units) by Type (2021–2026)
 Table 51. Global Leukapheresis Device Sales (K Units) by Type (2027–2032)
 Table 52. Global Leukapheresis Device Sales Market Share by Type (2021–2026)
 Table 53. Global Leukapheresis Device Sales Market Share by Type (2027–2032)
 Table 54. Global Leukapheresis Device Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Leukapheresis Device Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Leukapheresis Device Revenue Market Share by Type (2021–2026)
 Table 57. Global Leukapheresis Device Revenue Market Share by Type (2027–2032)
 Table 58. Global Leukapheresis Device Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Leukapheresis Device Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Leukapheresis Device Sales (K Units) by Application (2021–2026)
 Table 61. Global Leukapheresis Device Sales (K Units) by Application (2027–2032)
 Table 62. Global Leukapheresis Device Sales Market Share by Application (2021–2026)
 Table 63. Global Leukapheresis Device Sales Market Share by Application (2027–2032)
 Table 64. Global Leukapheresis Device Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Leukapheresis Device Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Leukapheresis Device Revenue Market Share by Application (2021–2026)
 Table 67. Global Leukapheresis Device Revenue Market Share by Application (2027–2032)
 Table 68. Global Leukapheresis Device Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Leukapheresis Device Price (US$/Unit) by Application (2027–2032)
 Table 70. Asahi Kasei Medical Company Information
 Table 71. Asahi Kasei Medical Description and Business Overview
 Table 72. Asahi Kasei Medical Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Asahi Kasei Medical Leukapheresis Device Product
 Table 74. Asahi Kasei Medical Recent Developments/Updates
 Table 75. Haemonetics Company Information
 Table 76. Haemonetics Description and Business Overview
 Table 77. Haemonetics Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Haemonetics Leukapheresis Device Product
 Table 79. Haemonetics Recent Developments/Updates
 Table 80. TERUMO BCT Company Information
 Table 81. TERUMO BCT Description and Business Overview
 Table 82. TERUMO BCT Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. TERUMO BCT Leukapheresis Device Product
 Table 84. TERUMO BCT Recent Developments/Updates
 Table 85. STEMCELL Technologies Company Information
 Table 86. STEMCELL Technologies Description and Business Overview
 Table 87. STEMCELL Technologies Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. STEMCELL Technologies Leukapheresis Device Product
 Table 89. STEMCELL Technologies Recent Developments/Updates
 Table 90. Fresenius Company Information
 Table 91. Fresenius Description and Business Overview
 Table 92. Fresenius Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Fresenius Leukapheresis Device Product
 Table 94. Fresenius Recent Developments/Updates
 Table 95. B. Braun Melsungen Company Information
 Table 96. B. Braun Melsungen Description and Business Overview
 Table 97. B. Braun Melsungen Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. B. Braun Melsungen Leukapheresis Device Product
 Table 99. B. Braun Melsungen Recent Developments/Updates
 Table 100. AllCells Company Information
 Table 101. AllCells Description and Business Overview
 Table 102. AllCells Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. AllCells Leukapheresis Device Product
 Table 104. AllCells Recent Developments/Updates
 Table 105. StemExpress Company Information
 Table 106. StemExpress Description and Business Overview
 Table 107. StemExpress Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. StemExpress Leukapheresis Device Product
 Table 109. StemExpress Recent Developments/Updates
 Table 110. Charles River Company Information
 Table 111. Charles River Description and Business Overview
 Table 112. Charles River Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Charles River Leukapheresis Device Product
 Table 114. Charles River Recent Developments/Updates
 Table 115. Precision for Medicine Company Information
 Table 116. Precision for Medicine Description and Business Overview
 Table 117. Precision for Medicine Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Precision for Medicine Leukapheresis Device Product
 Table 119. Precision for Medicine Recent Developments/Updates
 Table 120. Lonza Company Information
 Table 121. Lonza Description and Business Overview
 Table 122. Lonza Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Lonza Leukapheresis Device Product
 Table 124. Lonza Recent Developments/Updates
 Table 125. Grifols Company Information
 Table 126. Grifols Description and Business Overview
 Table 127. Grifols Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Grifols Leukapheresis Device Product
 Table 129. Grifols Recent Developments/Updates
 Table 130. Kaneka Medical Company Information
 Table 131. Kaneka Medical Description and Business Overview
 Table 132. Kaneka Medical Leukapheresis Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Kaneka Medical Leukapheresis Device Product
 Table 134. Kaneka Medical Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Leukapheresis Device Distributors List
 Table 138. Leukapheresis Device Customers List
 Table 139. Leukapheresis Device Market Trends
 Table 140. Leukapheresis Device Market Drivers
 Table 141. Leukapheresis Device Market Challenges
 Table 142. Leukapheresis Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Leukapheresis Device
 Figure 2. Global Leukapheresis Device Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Leukapheresis Device Market Share by Type: 2025 & 2032
 Figure 4. Monoclonal Acquisition Equipment Product Picture
 Figure 5. Leukocyte Separation Column Product Picture
 Figure 6. Leukocyte Removal Filter Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Leukapheresis Device Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Leukapheresis Device Market Share by Application: 2025 & 2032
 Figure 10. Academic Research
 Figure 11. Clinical Treatment
 Figure 12. Other
 Figure 13. Global Leukapheresis Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Leukapheresis Device Market Size (US$ Million), 2021–2032
 Figure 15. Global Leukapheresis Device Sales (K Units), 2021–2032
 Figure 16. Global Leukapheresis Device Average Price (US$/Unit), 2021–2032
 Figure 17. Leukapheresis Device Report Years Considered
 Figure 18. Leukapheresis Device Sales Share by Manufacturers in 2025
 Figure 19. Global Leukapheresis Device Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Leukapheresis Device Players: Market Share by Revenue in Leukapheresis Device in 2025
 Figure 21. Leukapheresis Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Leukapheresis Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Leukapheresis Device Sales Market Share by Country (2021–2032)
 Figure 24. North America Leukapheresis Device Revenue Market Share by Country (2021–2032)
 Figure 25. United States Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Leukapheresis Device Sales Market Share by Country (2021–2032)
 Figure 28. Europe Leukapheresis Device Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Leukapheresis Device Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Leukapheresis Device Revenue Market Share by Region (2021–2032)
 Figure 36. China Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Southeast Asia Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Leukapheresis Device Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Leukapheresis Device Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Colombia Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Leukapheresis Device Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Leukapheresis Device Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Leukapheresis Device Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Leukapheresis Device by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Leukapheresis Device by Type (2021–2032)
 Figure 56. Global Leukapheresis Device Price (US$/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Leukapheresis Device by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Leukapheresis Device by Application (2021–2032)
 Figure 59. Global Leukapheresis Device Price (US$/Unit) by Application (2021–2032)
 Figure 60. Leukapheresis Device Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS